Treatment of New World cutaneous leishmaniasis with miltefosine (Q28259788)

Europe PubMed Central

title

Treatment of New World cutaneous leishmaniasis with miltefosine (English)

1 reference

mucocutaneous leishmaniasis

27 March 2017

main subject

cutaneous leishmaniasis

1 reference

1 reference

1 reference

J Soto

1

0 references

J Berman

series ordinal

2

0 references

J. Soto

series ordinal

1

1 reference

27 March 2017

J. Berman

series ordinal

2

1 reference

27 March 2017

language of work or name

English

0 references

publication date

December 2006

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

27 March 2017

published in

1 reference

27 March 2017

volume

100 Suppl 1

0 references

100

1 reference

27 March 2017

page(s)

S34-40

0 references

S34-S40

1 reference

Evaluation of a direct immunofluorescent antibody (DIFMA) test using Leishmania genus-specific monoclonal antibody in the routine diagnosis of cutaneous leishmaniasis

27 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Miltefosine for new world cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Identification of Leishmania spp. by multiple isozyme analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

The natural history of cutaneous leishmaniasis in Guatemala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2006.02.022

2 references

27 March 2017

Consolidated OpenCitations Corpus – April 2017

release_s45m4vwryzc27ky5bms7wqp3gi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s45m4vwryzc27ky5bms7wqp3gi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16930649

1 reference

Consolidated OpenCitations Corpus – April 2017